Orca Capital holds 2,033 shares in Healthcare Triangle (HCTI) after registered offering

Rhea-AI Filing Summary

Healthcare Triangle, Inc. reports via a Schedule 13G/A that Orca Capital beneficially owns 2,033 shares of common stock, equal to 0.2% of the class.

Ownership percentages are calculated based on 1,155,370 shares outstanding immediately after the issuer's registered offering as stated in the prospectus supplement filed pursuant to Rule 424(b)(5) on February 27, 2026.

Insights

Governance & Ownership Analyst

Minor passive stake reported by European investor.

Orca Capital is shown holding 2,033 shares representing 0.2% of outstanding common stock under the Schedule 13G/A filing dated 03/04/2026. The filing characterizes this as ownership of 5% or less of a class.

Because the stake is small, the filing is routine and unlikely to change corporate control; subsequent disclosures would be required if the holding surpasses 5% or the holder changes its reporting status.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 04:30 PM Learn about SEC filing dates

FAQ

What stake does Orca Capital report in HCTI?

Orca Capital reports beneficial ownership of 2,033 shares, representing 0.2% of Healthcare Triangle's common stock. The percentage uses an outstanding share base of 1,155,370 shares after a registered offering disclosed in the prospectus supplement filed on February 27, 2026.

When is the outstanding share count used to calculate HCTI ownership?

The filing states percentages are based on 1,155,370 shares outstanding immediately after the issuer's registered offering. That offering is referenced via a prospectus supplement filed pursuant to Rule 424(b)(5) on February 27, 2026.

Does the Schedule 13G/A show voting or dispositive power for Orca Capital?

Yes. Orca Capital reports sole voting power and sole dispositive power over the 2,033 shares. The filing shows 0 shared voting and 0 shared dispositive power for this holding.

Does this filing indicate Orca Capital plans to acquire more HCTI shares?

No acquisition plans are stated. The Schedule 13G/A reports current beneficial ownership of 2,033 shares and classifies the holding as ownership of 5% or less; it does not disclose any intended purchases or sales.

What filing status does Orca Capital use for this disclosure?

Orca Capital filed a Schedule 13G/A, an amendment indicating passive or qualifying institutional ownership under Section 13 of the Exchange Act. The cover date in the submission is 03/04/2026 with signature on 03/05/2026.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Healthcare Triangle, Inc.

(Name of Issuer)

Common Stock, par value $0.00001 per share

(Title of Class of Securities)

03/04/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

Orca Capital AG

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

GERMANY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,033.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,033.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,033.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.2 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: All ownership percentages set forth in this Schedule 13G are calculated based upon an aggregate of 1,155,370 shares of Common Stock outstanding immediately after giving effect to the completion of the Issuer's registered offering as provided in the Issuer's Prospectus Supplement filed pursuant to Rule 424(b)(5) with the Securities and Exchange Commission on February 27, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Healthcare Triangle, Inc.
(b)	Address of issuer's principal executive offices: 7901 Stoneridge Drive, Suite 210, Pleasanton, CA 94588
Item 2.
(a)	Name of person filing: Orca Capital AG
(b)	Address or principal business office or, if none, residence: Sperlring 2 85276 Hettenshausen Deutschland
(c)	Citizenship: Germany
(d)	Title of class of securities: Common Stock, par value $0.00001 per share
(e)	CUSIP No.: 42227W405
Item 4.	Ownership
(a)	Amount beneficially owned: 2,033
(b)	Percent of class: 0.2%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,033
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,033
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Orca Capital AG

Signature:	/s/ Thomas Konig
Name/Title:	Thomas Konig/Director
Date:	03/05/2026